Stomach Neoplasms
233
25
34
99
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
18 trials with published results (8%)
Research Maturity
99 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
13 terminated out of 233 trials
88.4%
+1.9% vs benchmark
8%
18 trials in Phase 3/4
18%
18 of 99 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 99 completed trials
Clinical Trials (233)
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41
Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.
Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer